付 静, 沈中华, 程飞雄, 刘桂霞, 李卫华, 唐 赟. 芳香化酶的结构、催化机制及其抑制剂研究进展J. 药学学报, 2012,47(1): 18-28.
引用本文: 付 静, 沈中华, 程飞雄, 刘桂霞, 李卫华, 唐 赟. 芳香化酶的结构、催化机制及其抑制剂研究进展J. 药学学报, 2012,47(1): 18-28.
FU Jing, SHEN Zhong-hua, CHENG Fei-xiong, LIU Gui-xia, LI Wei-hua, TANG Yun. Progress in study of the structure, catalytic mechanism and inhibitors of aromataseJ. 药学学报, 2012,47(1): 18-28.
Citation: FU Jing, SHEN Zhong-hua, CHENG Fei-xiong, LIU Gui-xia, LI Wei-hua, TANG Yun. Progress in study of the structure, catalytic mechanism and inhibitors of aromataseJ. 药学学报, 2012,47(1): 18-28.

芳香化酶的结构、催化机制及其抑制剂研究进展

Progress in study of the structure, catalytic mechanism and inhibitors of aromatase

  • 摘要:

    芳香化酶是体内负责雌激素生物转化的限速酶。通过抑制芳香化酶活性调节雌激素水平成为治疗乳腺癌的另一途径本文首先简要介绍了芳香化酶的结构和催化机, 随后综述了甾体类和非甾体类芳香化酶抑制剂的研究进展, 并着重介绍了近年来发现的具有抑制芳香化酶活性的天然产物类抑制剂, 包括黄酮类、氧杂蒽酮类、香豆素类及倍半萜烯类化合物, 并分析了这些化合物的构效关系

     

    Abstract:

    Aromatase is a key enzyme responsible for in vivo estrogen biosynthesis.  Inhibition of the activity of the aromatase has become an alterative way for treatment of breast cancer.  In this review, the structure and catalytic mechanism of the aromatase is briefly introduced followed by thorough review of the progress in the study of the steroidal and non-steroidal aromatase inhibitors.  This review is focused on the natural compounds that exhibit the aromatase inhibition, which include flavonoids, xanthones, coumarins, and sesquiterpenes.  The structure-activity relationship of these compounds is also discussed.

     

/

返回文章
返回